The PositionThe Director, Real World Evidence (RWE) leads the development and execution of RWE for the assigned therapeutic area or function area through serving as the principal investigator on real world evidence studies. The incumbent acts as a the scientific leader in the conduct of the research in assigned therapeutic area with NNI stakeholders within Clinical, Medical and Regulatory Affairs (CMR), Market Access and Public Affairs, as well as a liaison to therapeutically aligned global counterparts in Epidemiology, Data Science and Real-World Evidence. The Director leads the study team and communicates the RWE project execution to internal and external stakeholders on behalf of RWE study team and USO. S/he manages partner relationships, vendors and strategic collaborations on behalf of CDSE. The Director serves as the lead researcher on the assigned studies within the therapeutic area team or function area. This individual works closely with external experts, vendors and internal functions including medical affairs, biostatistics and data science functions to execute studies.
RelationshipsThe Director, RWE reports to the Senior Director & TA head in CDSE. The Director is responsible for a cross-functional RWE study team and demonstrates proactive stakeholder engagement and associated RWE execution, communication of RWE studies to internal and external stakeholders and leadership in the use of appropriate RWE/HEOR methodologies.
Essential Functions- RWE study leadership
- Leads and manages the execution of all RWE assigned within the therapeutic area conducted internally, with partners and with vendors
- Utilizes the NN Real World Data platform, partnership platforms and analytic tools
- Develops and maintains stakeholder relationships to ensure optimal utility of RWD within USO
- Mentors junior staff
- RWE Communication
- Communicates the RWE to key internal stakeholders within assigned therapeutic area responsibilities
- Communicates RWE to customers and scientific community via publication and conferences
- Leadership in RWE methods
- Serves as reviewer for the CDSE Protocol Review Committee
- Acts as a key subject matter expert in various methodological and advanced analytic functions and provides consultation to / collaborates with key internal and external stakeholders directly to provide tangible solutions that are aligned to portfolio strategy
Physical Requirements10-20% overnight travel required.
Qualifications- At least 8-10 years of experience in leading the development of RWE
- At least 8-10 years of experience in key stakeholder engagement roles
- Experience in RWE methodologies and advanced analytics
- Demonstrated prior research accomplishment (e.g., publications in peer-reviewed journals and presentations at scientific conferences)
- Excellent leadership, strong communication and critical thinking skills with keen knowledge of real-world databases
- Excellent process and project management skills required including the ability to manage a significant volume of projects with exercise of good triage and judgment skills
- Keen knowledge and at least 8 years of experience in research using real world data and its applications in clinical and business decision making
- PhD Preferred or Master's degree in appropriate field required (e.g., epidemiology, biostatistics, health services research, health economics)
- Strong business acumen and a team player
- Strong strategic thinking skills
The base compensation range for this position is $187,100 to $327,500. Base compensation is determined based on a number of factors. This position is also eligible for a company bonus based on individual and company performance. Novo Nordisk offers long-term incentive compensation and or company vehicles depending on the position's level or other company factors.
Employees are also eligible to participate in Company employee benefit programs including medical, dental and vision coverage; life insurance; disability insurance; 401(k) savings plan; flexible spending accounts; employee assistance program; tuition reimbursement program; and voluntary benefits such as group legal, critical illness, identity theft protection, pet insurance and auto/home insurance. The Company also offers time off pursuant to its sick time policy, flex-able vacation policy, and parental leave policy.
